Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced activities highlighting the latest data and experience with the Tryton Side Branch Stent at EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions, taking place at the Palais des Congrès May 20-23, 2014 in Paris.
from Content Keyword RSS http://ift.tt/1olgErJ
via IFTTT
from Content Keyword RSS http://ift.tt/1olgErJ
via IFTTT
No comments:
Post a Comment